IV Legalon refers to the intravenous administration of a standardized extract of milk thistle, known as silymarin. This form of therapy supports and restores liver function by delivering the active components directly into the bloodstream, bypassing the first-pass metabolic effect of the stomach and liver.
What Is IV Legalon?
IV Legalon is a pharmaceutical product containing silymarin, a flavonolignan complex derived from the fruits of the milk thistle plant (Silybum marianum). Its primary active component, silibinin (or silibin), has powerful antioxidant, anti-inflammatory, and hepatoprotective properties. Intravenous administration ensures direct entry into the bloodstream, providing maximum bioavailability and rapid therapeutic effect.
Conclusion
IV Legalon is a powerful therapeutic option for supporting and restoring liver function. By delivering active compounds directly to the target cells, it ensures high bioavailability and therapeutic efficiency. This method is particularly suitable for patients with chronic liver issues, those exposed to high toxic loads, or those in need of urgent liver support.
Important: Treatment should always be administered under the supervision of qualified medical professionals to ensure safety and effectiveness.
